ID: MRFR/LS/2319-HCR | February 2021 | Region: Global | 72 pages
$1300.6 Million
12.3%
North America
2022-2030
Market Synopsis of Anti-nuclear Antibody (ANA) Testing Market:
Anti-nuclear Antibody (ANA) Test is used to detect antinuclear antibodies in blood. Immune system makes antibodies to fight with various infections. Antinuclear antibodies often attack on own tissues. ANA test helps to determine autoimmune diseases like rheumatoid arthritis and lupus. Increasing technological advancements, adoption of new techniques and increasing prevalence of various autoimmune diseases are driving the growth for anti-nuclear antibody (ANA) testing market. Major brands are investing money in R&D to develop more advanced product for the market that is another key driver for the market.
The Anti-nuclear Antibody (ANA) testing market is growing at the CAGR of ~9.6% during the forecast period and expected to reach US$ 1300.6 million by 2023.
Key Players for Anti-nuclear Antibody (ANA) Testing Market:
Some of the key players in this market are: Abcam plc. (US), Alere (US), Antibodies Inc.(US), Bio-Rad Laboratories, Inc. (US), Erba Diagnostics (US), Indur Services, Inc. (US), MBL INTERNATIONAL (US), Merck KGaA (Germany), Trinity Biotech (Republic of Ireland)
Intended Audience
Market Segments:
Anti-nuclear Antibody (ANA) Testing Market has been segmented on the basis of type which comprise immunofluorescence (Primary or direct and Secondary or indirect), enzymelinked, immunosorbent assay (ELISA) (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competition/Inhibition ELISA), and others. On the basis of application, it segmented into Rheumatoid arthritis (Seropositive, Seronegative), Systemic lupus erythematosus (SLE) (Discoid lupus erythematosus, Subacute cutaneous lupus erythematosus, Neonatal lupus), Polymyositis, Scleroderma (localized scleroderma, systemic scleroderma), Sjögren's syndrome (Primary, secondary) , and others. On the basis of end user, it segmented into Hospitals and clinics, research laboratories, and others.
FIGURE 1 ANTI-NUCLEAR ANTIBODY (ANA) TESTING MARKET SHARE, BY APPLICATION (%)
Study objectives of Anti-nuclear Antibody (ANA) Testing Market:
Regional Analysis of Anti-nuclear Antibody (ANA) Testing Market:
Considering the global scenario of the market, North America is largest market for Anti-nuclear Antibody (ANA) Testing, in North America region US hold largest market share while European market is second largest, and especially the growth rate is higher in west European countries. On the other hand, Asia-Pacific (APAC) is fastest growing market and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment.
Anti-nuclear Antibody (ANA) Testing Market, by Region
Research Methodology:
Sources: Directorate of Industries, Annual report, White paper, Company Presentation
The report for Anti-nuclear Antibody (ANA) Testing Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Frequently Asked Questions (FAQ) :
Anti-Nuclear Antibody Testing Market is projected to grow at a 9.6% CAGR between 2017-2023.
Anti-Nuclear Antibody Testing Market predicted to touch USD 1300.6 million by 2023.
North America is expected to dominate the Anti-Nuclear Antibody Testing Market.
Different end user industries of Anti-Nuclear Antibody Testing Market include research laboratories, hospital and clinics, and others.
Different strategies used by market players to create a dominance in the Anti-Nuclear Antibody Testing Market include mergers, acquisitions, collaborations, and product launches.